Blackcrane Capital Portfolio holdings
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$11.3M |
| 2 |
Americold
COLD
|
+$9.5M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$6.27M |
Top Sells
| 1 |
Visa
V
|
+$6.94M |
| 2 |
Guidewire Software
GWRE
|
+$6.54M |
| 3 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
+$6.25M |
| 4 |
AKTS
Akoustis Technologies Inc
AKTS
|
+$4.44M |
| 5 |
Nice
NICE
|
+$3.2M |
Sector Composition
| 1 | Healthcare | 33.42% |
| 2 | Technology | 33.18% |
| 3 | Energy | 14.05% |
| 4 | Real Estate | 13.31% |
| 5 | Financials | 6.04% |
Similar funds
Blackcrane Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Blackcrane Capital held 12 positions worth $75.2M, down 4.7% from $78.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blackcrane Capital withdrew a net $3.43M in Q3 2019, closing 3 positions and reducing 6 holdings. Its most notable exit was Guidewire Software, an estimated $6.54M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
Against the trend, Blackcrane Capital opened a new position in Biohaven Pharmaceutical Holding Company Ltd. worth $11.2M.
- Blackcrane Capital's largest Q3 2019 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,728 shares worth $11.2M.
- Blackcrane Capital's biggest Q3 2019 reduction was Visa, cutting an estimated $6.94M.
- Blackcrane Capital fully exited Guidewire Software in Q3 2019, selling an estimated $6.54M.
- Blackcrane Capital's ten largest holdings make up 100% of its $75.2M portfolio in Q3 2019.
- Blackcrane Capital opened 3 new positions and closed 3 in Q3 2019.
- Blackcrane Capital's portfolio value fell 4.7% quarter-over-quarter to $75.2M.
Based on Blackcrane Capital's 13F filing for Q3 2019, filed 7 Nov 2019.